EUVIMEDEUVIMED entdecken
Crossref

Quercetin‐4′‐O‐β‐D‐glucopyranoside inhibits podocyte injury by SIRT5 ‐mediated desuccinylation of NEK7

Menghua Wu, Xiaoli Ye

Clinical and Experimental Pharmacology and Physiology · 2024

DOI: 10.1111/1440-1681.13909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2024. Verfasst von Menghua Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Ch…. Hauptthemen laut MEDLINE: Podocytes, NIMA-Related Kinases, Sirtuins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is a complication of diabetic mellitus. New treatments need to be developed. This study aimed to investigate the effects of quercetin‐4′‐O‐β‐D‐glucopyranoside (QODG) on podocyte injury. Podocytes were cultured in high glucose (HG) medium, treated with QODG, and overexpressing or knocking down SIRT5. Oxidative stress indicators were assessed using corresponding kits. Pyroptosis was detected by flow cytometry and western blot analysis. Succinylation modification was detected using immunoprecipitation (IP) and western blot analysis. The interaction between NEK7 and NLRP3 was determined by co‐IP. The results indicated that QODG inhibited oxidative stress and pyroptosis of podocytes induced by HG. Besides, QODG suppressed succinylation levels in HG‐induced podocytes, with the upregulation of SIRT5. Knockdown of SIRT5 reversed the effects of QODG on oxidative stress and pyroptosis. Moreover, SIRT5 inhibited the succinylation of NEK7 and the interaction between NLRP3 and NEK7. In conclusion, QODG upregulates SIRT5 to inhibit the succinylation modification of NEK7, impedes the interaction between NEK7 and NLRP3, and then inhibits the pyroptosis and oxidative stress injury of podocytes under HG conditions. The findings suggested that QODG has the potential to treat DKD and explore a novel underlying mechanism of QODG function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesNIMA-Related KinasesSirtuinsAnimalsMiceOxidative StressPyroptosisNLR Family, Pyrin Domain-Containing 3 ProteinGlucosidesCell Line

Stichwörter der Autor:innen

NEK7QODGSIRT5desuccinylationoxidative stresspyroptosis

Substanzen

NIMA-Related KinasesSirtuinsNek7 protein, mouseSIRT5 protein, mouseNLR Family, Pyrin Domain-Containing 3 ProteinGlucosides

Autor:innen und Institutionen

  • Department of Pharmacy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Department of Party Building Office, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

Zitieren

APA

Wu, M., & Ye, X. (2024). Quercetin‐4′‐O‐β‐D‐glucopyranoside inhibits podocyte injury by SIRT5 ‐mediated desuccinylation of NEK7. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.13909

Vancouver

Wu M, Ye X. Quercetin‐4′‐O‐β‐D‐glucopyranoside inhibits podocyte injury by SIRT5 ‐mediated desuccinylation of NEK7. Clinical and Experimental Pharmacology and Physiology. 2024. doi:10.1111/1440-1681.13909

BibTeX
@article{Wu2024,
  author = {Wu, Menghua and Ye, Xiaoli},
  title = {Quercetin‐4′‐O‐β‐D‐glucopyranoside inhibits podocyte injury by SIRT5 ‐mediated desuccinylation of NEK7},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2024},
  doi = {10.1111/1440-1681.13909}
}
Kostenlos starten →